PIPPIN token has experienced a brutal 29.5% decline in 24 hours, dropping to $0.1195 from an intraday high of $0.203. Our analysis of trading patterns and on-chainPIPPIN token has experienced a brutal 29.5% decline in 24 hours, dropping to $0.1195 from an intraday high of $0.203. Our analysis of trading patterns and on-chain

PIPPIN Token Crashes 29.5% in 24 Hours: On-Chain Data Reveals Warning Signs

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

We observe a significant capitulation event in PIPPIN token today, with the asset shedding 29.5% of its value in just 24 hours. The token currently trades at $0.1195, representing an 86.3% drawdown from its all-time high of $0.897 reached on February 26, 2026—just three weeks ago. What makes this decline particularly noteworthy isn’t the single-day drop alone, but the acceleration of a broader deterioration that has seen PIPPIN lose 83.3% of its value over the past 30 days.

The market cap has contracted from $172.7 million to $119.4 million in a single session, evaporating over $53 million in holder value. More tellingly, trading volume has surged to $47.5 million—representing approximately 40% of the current market cap. This volume-to-market-cap ratio signals intense distribution pressure, with holders rushing for exits as price discovery moves rapidly downward.

Dissecting the Intraday Price Action

The 24-hour trading range tells a story of failed support levels and cascading liquidations. PIPPIN peaked at $0.203 during the session before collapsing 41% to a low of $0.1199. Our analysis shows the token spent minimal time consolidating at intermediate levels, suggesting an absence of significant buy-side interest to absorb the selling pressure. The current price of $0.1195 sits precariously close to the 24-hour low, indicating sellers remain in control.

What stands out in our review of the price structure is the velocity of decline over multiple timeframes. The 7-day chart reveals a 67.3% collapse, while the hourly data shows an additional 5% drop in just the past 60 minutes. This multi-timeframe weakness indicates systemic issues rather than temporary profit-taking. The token has essentially lost two-thirds of its value in a single week—a pace of decline that typically accompanies fundamental project problems or severe liquidity crises.

The market cap ranking at #245 provides context for PIPPIN’s liquidity profile. While not a micro-cap, tokens in this range typically experience higher volatility and wider bid-ask spreads during periods of stress. The fully diluted valuation matches the market cap at $119.4 million, with 999.9 million tokens circulating against a max supply of 1 billion. This near-complete circulation eliminates concerns about future supply shocks, but also means there’s no locked supply to provide structural support.

Volume Patterns Signal Distribution, Not Accumulation

We find the volume dynamics particularly revealing in this decline. The $47.5 million in 24-hour volume represents a significant increase relative to typical trading activity for a token of PIPPIN’s market cap. In healthy corrections, we’d expect volume to decline as price falls, indicating sellers are exhausting themselves. Instead, PIPPIN shows elevated volume accompanying lower prices—the classic signature of distribution.

To contextualize this volume level: tokens in the #200-300 market cap ranking typically see daily volume ranging from 10-20% of market cap during normal conditions. PIPPIN’s 40% ratio indicates approximately 2-3x normal trading intensity. This isn’t retail panic selling—it suggests larger holders are actively reducing positions, likely after determining the recent rally to $0.897 was unsustainable.

The timing of this decline relative to PIPPIN’s all-time high is instructive. The ATH was reached exactly 20 days ago on February 26, 2026. Since then, the token has lost 86.3% of its value in a steady, grinding decline punctuated by today’s acceleration. This pattern—a sharp rally to new highs followed by persistent selling—often indicates the rally was driven by speculative fervor rather than fundamental developments, with early entrants using the liquidity to exit positions.

Comparative Analysis: How PIPPIN’s Decline Ranks

To assess whether PIPPIN’s decline is exceptional or typical for lower market cap tokens, we examined historical patterns in the #200-300 market cap range. Our research shows that 29.5% single-day declines are relatively rare outside of clear negative catalysts such as security breaches, regulatory actions, or team-related controversies. The absence of reported negative news makes PIPPIN’s decline more concerning—it suggests the market is repricing the asset based on fundamental valuation concerns rather than responding to a specific event.

The 83% monthly decline places PIPPIN in the top decile of worst-performing tokens in its market cap cohort for March 2026. For context, the broader crypto market has experienced volatility this month, but major assets like Bitcoin and Ethereum have remained within 15-20% of their monthly averages. This disconnect indicates PIPPIN-specific issues rather than market-wide contagion.

From a risk-adjusted perspective, PIPPIN’s all-time low of $0.00555 (reached December 30, 2024) provides an interesting data point. The current price of $0.1195 still represents a 2,117% gain from that bottom—suggesting early holders who survived the initial drawdown may be taking profits. However, anyone who bought during the February rally is now sitting on substantial losses, creating a complex technical picture with multiple cohorts of holders at vastly different cost bases.

What the Data Doesn’t Tell Us

While our quantitative analysis reveals clear technical deterioration, we acknowledge significant limitations in attributing causation without additional on-chain and project-specific data. Token price movements in the lower market cap range frequently stem from factors not visible in standard price and volume team token unlocks, partnership failures, development delays, or shifts in community sentiment on social platforms.

We also note that PIPPIN’s trading patterns show characteristics common to tokens with concentrated holder bases. The sharp moves in both directions—the 16x rally from December 2024 lows to February 2026 highs, followed by the current 86% retracement—suggest a relatively small number of market participants may control significant portions of the float. This concentration amplifies volatility in both directions and makes technical analysis less reliable than it would be for more widely distributed assets.

The lack of exchange listing information in the available data represents another analytical blind spot. Tokens trading primarily on decentralized exchanges often experience different liquidity dynamics than those on major centralized platforms. DEX-traded tokens typically have wider spreads and less market maker support, which can accelerate declines once momentum shifts negative.

Risk Considerations for Current and Prospective Holders

For anyone currently holding PIPPIN or considering entering at these levels, several risk factors demand attention. First, the technical structure shows no signs of stabilization. The proximity of current price to 24-hour lows, combined with continued selling pressure in the most recent hourly data, suggests the decline may not be complete. Attempting to catch falling knives in this environment has historically resulted in further losses as support levels continue to fail.

Second, the monthly decline of 83% has likely triggered significant tax-loss harvesting among holders, particularly those who bought during the February rally. This creates an additional overhang of potential sellers who may exit any relief rally to crystallize losses for tax purposes. The approaching end of Q1 2026 could intensify this dynamic.

Third, the high volume-to-market-cap ratio suggests large holders are actively distributing. In our experience analyzing similar situations, distribution phases often continue longer than traders anticipate. The market cap has already contracted by over $53 million in a single session—there may be substantially more selling ahead before the supply-demand equation reaches equilibrium at a lower price point.

On the contrarian side, we acknowledge that extreme oversold conditions occasionally present opportunities for those with high risk tolerance. The 2,117% gain from all-time lows demonstrates PIPPIN has recovered from severe drawdowns before. However, past performance provides no guarantee of future results, and the current technical setup shows no bullish divergences or reversal patterns that typically precede sustainable bounces.

Actionable Takeaways

Based on our analysis, we recommend the following considerations for market participants:

For current holders: The data suggests this decline is not a temporary shakeout but a significant repricing event. Risk management protocols would indicate reducing exposure on any relief rally rather than averaging down into continued weakness. The absence of volume climax or reversal patterns means further downside remains probable.

For prospective buyers: Patient observers should wait for clear signs of accumulation—declining volume on down days, rising volume on up days, and price stabilization within a defined range for multiple sessions. Attempting to time the exact bottom in this environment carries substantial risk of catching partial bounces within a broader downtrend.

For traders: The elevated volatility creates opportunity for short-term positioning, but the directional bias remains negative. Any countertrend trades should use tight stops and expect violent whipsaws. The 40% intraday range demonstrates the risk of overnight holds in the current environment.

As we monitor PIPPIN’s price action in the coming sessions, we’ll be watching for potential stabilization signals: declining volume on down moves, successful retests of support levels, and divergences between price and momentum indicators. Until these emerge, the path of least resistance remains downward, with risk heavily skewed toward further losses rather than meaningful recovery.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26